Primary Navigation for the CDC Web Site
CDC en Español
National Breast and Cervical Cancer Early Detection Program
divider
E-Mail Icon E-mail this page
Printer Friendly Icon Printer-friendly version
divider
 View by Topic
bullet About the Program
bullet Find a Local Program
bullet Program Highlights
bullet Reimbursement Policy
bullet Screening Program Data
bullet Screening Program Summaries
bullet National Aggregate
bullet Publications
bullet Training
bullet Legislation
bullet Partners
bullet Related Links

Contact Information Centers for Disease
Control and Prevention
Division of Cancer
Prevention and Control
4770 Buford Hwy, NE
MS K-64
Atlanta, GA 30341-3717

Call: 1 (800) CDC-INFO
TTY: 1 (888) 232-6348
FAX: (770) 488-4760

E-mail: cdcinfo@cdc.gov

Submit a Question Online

National Aggregate

On this page

Tables and graphs report on cancer screening services provided through the program in a recent 5-year period. The data represent clinical services funded directly through the NBCCEDP as reported in the April 2008 submission of the NBCCEDP Minimum Data Elements (MDE).

National aggregate data are typically used to report results from the program and as a standard to compare results of grantee programs. Comparing data across grantee programs is not advised due to extensive variation across programs. For information on interpreting the data, refer to Screening Program Data. For information on the program, refer to About the Program.

Screening Totals by Year

Women Screened through the NBCCEDP, by Year
7/2002 to 6/2007
National Aggregate
This bar graph illustrates the number of women who received NBCCEDP-funded screenings by program year from 7/2002 to 6/2007
See text description of this graph.

Program Overview

Women Served through the NBCCEDP
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
Women served* 1,879,496
Women screened** 1,824,338
Women receiving mammography 1,146,391
Women receiving Pap tests 1,118,235
Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category.

* Women served includes women receiving any NBCCEDP-funded screen or diagnostic procedure.

** Women screened includes women receiving any NBCCEDP-funded screen (mammography, clinical breast exam, or Pap test).

Data Source: April 2008 submission of NBCCEDP Minimum Data Elements (MDE)

Cervical Cancer Screening

Distribution by Race/Ethnicity
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
This pie chart illustrates the percent distribution of women who received NBCCEDP-funded Pap tests by race/ethnicity from 7/2002 to 6/2007.
Women receiving an NBCCEDP-funded Pap test = 1,118,235
Distribution by Age
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
This pie chart illustrates the percent distribution of women who received NBCCEDP-funded Pap tests by age from 7/2002 to 6/2007.
Women receiving an NBCCEDP-funded Pap test = 1,118,235
See text description of these graphs.


Cervical Cancer Screening Results and Outcomes
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
Pap tests provided 1,641,972
Pap tests with abnormal results* 45,746
     Percentage of Pap tests with abnormal results 2.8
     Age-adjusted percentage** 2.4
Cervical cancers or cancer precursor lesions detected*** 25,152
     CIN-1 or LSIL 13,756
     CIN-2 or worse**** 11,396
     Rate of CIN-2 or worse detected per 1,000 Pap tests**** 6.9
     Age-adjusted rate per 1,000 Pap tests** 5.7
* Abnormals include Pap test results of: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance – cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer.

** Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000.

*** Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)-1, CIN-2, CIN-3, carcinoma in situ (CIS), and invasive cervical cancer.

**** Includes HSIL, CIN-2, CIN-3, CIS, and invasive cervical cancer.

Table includes only NBCCEDP-funded Pap tests. An additional 28,745 women, not included above, were diagnosed with LSIL, HSIL, CIN-1, CIN-2, CIN-3, CIS, or invasive cervical cancer through the NBCCEDP following a Pap test funded through another source.

Breast Cancer Screening

Distribution by Race/Ethnicity
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
This pie chart illustrates the percent distribution of women who received NBCCEDP-funded mammograms by race/ethnicity from 7/2002 to 6/2007.
Women receiving an NBCCEDP-funded mammogram = 1,146,391
Distribution by Age
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
This pie chart illustrates the percent distribution of women who received NBCCEDP-funded mammograms by age from 7/2002 to 6/2007.
Women receiving an NBCCEDP-funded mammogram = 1,146,391
See text description of these graphs.


Breast Cancer Screening Results and Outcomes
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
Mammograms provided 1,785,597
Abnormal mammograms* 217,887
     Percentage of abnormal mammograms 12.2
     Age-adjusted percentage** 12.0
Breast cancers detected*** 14,682
     Rate of breast cancers detected per 1,000 mammograms 8.2
     Age-adjusted rate per 1,000 mammograms** 8.2
* Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete.

** Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000.

*** Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS).

Table includes only NBCCEDP-funded mammograms provided to women age 40 and older. An additional 4,500 women, not included above, were diagnosed with CIS (other), DCIS, or invasive breast cancer through the NBCCEDP following a mammogram funded through another source.

Text Description of Screening Totals by Year Graph

Women Screened through the NBCCEDP, by Year
7/2002 to 6/2007
National Aggregate
Year Women Screened Women Receiving
NBCCEDP-Funded Mammograms
Women Receiving
NBCCEDP-Funded Pap Tests
PY2003 548,768 343,187 291,317
PY2004 592,187 376,008 304,660
PY2005 621,204 387,051 328,261
PY2006 626,210 374,205 353,279
PY2007 524,256 295,338 318,220
Return to the Screening Totals by Year section

Text Description of Cervical Cancer Screening Graphs

Distribution by Race/Ethnicity
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
Race Percentage
White 46.7
Black 13.4
Asian/Pacific Islander 5.1
American Indian/Alaska Native 5.3
Multiracial 0.6
Hispanic 27.0
Unknown 1.8
Women receiving an NBCCEDP-funded Pap test = 1,118,235


Distribution by Age
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
Age Percentage
<30 8.4
30–39 10.2
40–49 37.2
50–64 42.8
65+ 1.4
Unknown < 0.1
Women receiving an NBCCEDP-funded Pap test = 1,118,235

Return to the Cervical Cancer Screening section

Text Description of Breast Cancer Screening Graphs

Distribution by Race/Ethnicity
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
Race Percentage
White 39.8
Black 14.1
Asian/Pacific Islander 6.3
American Indian/Alaska Native 3.3
Multiracial 0.4
Hispanic 33.8
Unknown 2.3
Women receiving an NBCCEDP-funded mammogram = 1,146,391


Distribution by Age
Five-Year Summary, 7/2002 to 6/2007
National Aggregate
Age Percentage
<40 2.1
40–49 27.5
50–64 67.6
65+ 2.8
Unknown < 0.1
Women receiving an NBCCEDP-funded mammogram = 1,146,391

Return to the Breast Cancer Screening section

Page last reviewed: August 29, 2008
Page last updated: August 29, 2008
Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention
1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
USA.govDHHS Department of Health
and Human Services